000 | 01000 a2200301 4500 | ||
---|---|---|---|
005 | 20250517073705.0 | ||
264 | 0 | _c20160513 | |
008 | 201605s 0 0 eng d | ||
022 | _a1530-0293 | ||
024 | 7 |
_a10.1097/CCM.0000000000001527 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aCordeiro Ventura, Andrea | |
245 | 0 | 0 |
_aThe authors reply. _h[electronic resource] |
260 |
_bCritical care medicine _cFeb 2016 |
||
300 |
_ae111-2 p. _bdigital |
||
500 | _aPublication Type: Letter; Comment | ||
650 | 0 | 4 |
_aDopamine _xtherapeutic use |
650 | 0 | 4 |
_aEpinephrine _xtherapeutic use |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aHospital Mortality _xtrends |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aShock, Septic _xdrug therapy |
650 | 0 | 4 |
_aVasoconstrictor Agents _xtherapeutic use |
700 | 1 | _aShieh, Huei Hsin | |
773 | 0 |
_tCritical care medicine _gvol. 44 _gno. 2 _gp. e111-2 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1097/CCM.0000000000001527 _zAvailable from publisher's website |
999 |
_c25634838 _d25634838 |